Please do not leave this page until complete. This can take a few moments.
A hiring freeze is in place and the plan for future regulatory work is to be determined at the Cannabis Control Commission, as lawmakers advance a budget its executive director has said is inadequate as well as legislation to entirely restructure
Startups have navigated the perilous Valley of Death period with varying levels of success. Conifer Life Sciences Group at MBI is trying to change that.
A factory on Southbridge Street could be key in unlocking a faster and more cost-effective way to fight the housing crisis: modular construction.
In addition to considering mergers, local beer firms have begun to explore expanding their offerings to stay competitive.
Metal Supermarkets offers 8,000 shapes and grades of metal, tailored to customers’ specific needs.
Asked what makes the CCC's existing model unworkable, Mariano said it was a structural problem but gave a conflicted explanation.
Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.
Rep. Marcus Vaughn of Wrentham proposed an amendment (#6) to put limits on the potency of legal marijuana products.
The House budget committee teed up cannabis legislation Tuesday morning, polling its members on legislation that would downsize the embattled Cannabis Control Commission and address industry pressure points ahead of a Wednesday formal session for
After nearly three years as CFO of Lifeward, Michael Lawless will retire from his role at the Marlborough-based mobility device manufacturer in late June.
Despite concerns about impacts of tariffs and cuts to federal incentives, heat pumps are becoming standard equipment in the heating and cooling business.
A key tool to help decarbonize New England’s electricity grid has already been in operation for over a century.
Rich Sneider served as the firm’s CFO since 1998.
Opponents, including Equitable Opportunities Now and the Massachusetts Cannabis Equity Council, have warned that multistate operators are able to spend heavily to increase their market share and that allowing them to grow even more will hurt small
The first five months of 2025 have been a wild ride for the economy. How has your outlook changed for the rest of the year?
Two months after its CFO abruptly resigned, Arch Therapeutics, a Framingham-based biotechnology company, has filed for Chapter 11 bankruptcy.